Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Analysis of patient outcomes following proton radiation therapy for retinoblastoma.

Mouw KW, Yeap BY, Caruso P, Fay A, Misra M, Sethi RV, MacDonald SM, Chen YL, Tarbell NJ, Yock TI, Freitag SK, Munzenrider JE, Grabowski E, Katz M, Kuhlthau K, DeCastro D, Heidary G, Ciralsky J, Mukai S, Shih HA.

Adv Radiat Oncol. 2017 Jan-Mar;2(1):44-52. doi: 10.1016/j.adro.2016.11.002.

2.

Proton radiation therapy for the treatment of retinoblastoma.

Mouw KW, Sethi RV, Yeap BY, MacDonald SM, Chen YL, Tarbell NJ, Yock TI, Munzenrider JE, Adams J, Grabowski E, Mukai S, Shih HA.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):863-9. doi: 10.1016/j.ijrobp.2014.07.031. Epub 2014 Sep 13.

3.

The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience.

Agarwal A, Thaker NG, Tawk B, Allen PK, Grosshans DR, Herzog CE, Gombos DS, Mahajan A.

Int J Part Ther. 2016 Mar;2(4):490-498. doi: 10.14338/IJPT-15-00016.1. Epub 2016 Mar 24.

4.

Long-term follow-up of retinoblastoma survivors: Experience from India.

Seth R, Singh A, Guru V, Chawla B, Pathy S, Sapra S.

South Asian J Cancer. 2017 Oct-Dec;6(4):176-179. doi: 10.4103/sajc.sajc_179_16.

5.

Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.

Sato M, Gunther JR, Mahajan A, Jo E, Paulino AC, Adesina AM, Jones JY, Ketonen LM, Su JM, Okcu MF, Khatua S, Dauser RC, Whitehead WE, Weinberg J, Chintagumpala MM.

Cancer. 2017 Jul 1;123(13):2570-2578. doi: 10.1002/cncr.30623. Epub 2017 Mar 7.

6.

Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients.

Gross JP, Powell S, Zelko F, Hartsell W, Goldman S, Fangusaro J, Lulla RR, Smiley NP, Chang JH, Gondi V.

Neuro Oncol. 2019 Jul 11;21(7):934-943. doi: 10.1093/neuonc/noz070.

PMID:
30997512
7.

How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.

Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, Biewald E, Mäusert J, Wieland R, Bornfeld N, Sauerwein W, Eggert A, Lohmann DR, Jöckel KH.

J Clin Oncol. 2016 Sep 10;34(26):3183-8. doi: 10.1200/JCO.2015.65.4012. Epub 2016 Jul 5.

PMID:
27382102
8.

Psychosocial Outcomes in Adult Survivors of Retinoblastoma.

Ford JS, Chou JF, Sklar CA, Oeffinger KC, Novetsky Friedman D, McCabe M, Robison LL, Kleinerman RA, Li Y, Marr BP, Abramson DH, Dunkel IJ.

J Clin Oncol. 2015 Nov 1;33(31):3608-14. doi: 10.1200/JCO.2014.60.5733. Epub 2015 Sep 28.

9.

Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.

Weber DC, Lomax AJ, Rutz HP, Stadelmann O, Egger E, Timmermann B, Pedroni ES, Verwey J, Miralbell R, Goitein G; Swiss Proton Users Group.

Radiother Oncol. 2004 Jun;71(3):251-8.

PMID:
15172139
10.

Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.

Eaton BR, Esiashvili N, Kim S, Patterson B, Weyman EA, Thornton LT, Mazewski C, MacDonald TJ, Ebb D, MacDonald SM, Tarbell NJ, Yock TI.

Neuro Oncol. 2016 Jun;18(6):881-7. doi: 10.1093/neuonc/nov302. Epub 2015 Dec 19.

11.

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.

Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):946-53. doi: 10.1016/j.ijrobp.2013.08.032. Epub 2013 Oct 15.

12.

Retinoblastoma in Turkey--treatment and prognosis.

Günalp I, Gündüz K, Arslan Y.

Jpn J Ophthalmol. 1996;40(1):95-102.

PMID:
8739506
13.
14.

Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).

Lumbroso-Le Rouic L, Savignoni A, Levy-Gabriel C, Aerts I, Cassoux N, Salviat F, Gauthier-Villars M, Freneaux P, Brisse H, Dendale R, Esteve M, Doz F, Desjardins L.

J Fr Ophtalmol. 2015 Jun;38(6):535-41. doi: 10.1016/j.jfo.2015.04.002. Epub 2015 May 11.

PMID:
25976136
15.

Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.

Yu JB, Soulos PR, Herrin J, Cramer LD, Potosky AL, Roberts KB, Gross CP.

J Natl Cancer Inst. 2013 Jan 2;105(1):25-32. doi: 10.1093/jnci/djs463. Epub 2012 Dec 14.

16.

Outcomes and complications after phacoemulsification in retinoblastoma patients with cataract after radiation treatment.

Velásquez-Aguilar M, Matiz-Moreno H, Amato-Almanza M, Chen-López CY, Márquez-García G, Ramírez-Ortiz MA.

Arch Soc Esp Oftalmol. 2017 Apr;92(4):160-165. doi: 10.1016/j.oftal.2016.11.011. Epub 2016 Dec 23. English, Spanish.

PMID:
28017486
17.

Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.

Wiltink LM, Nout RA, van der Voort van Zyp JR, Ceha HM, Fiocco M, Meershoek-Klein Kranenbarg E, Marinelli AW, van de Velde CJ, Marijnen CA.

Clin Colorectal Cancer. 2016 Sep;15(3):e93-9. doi: 10.1016/j.clcc.2016.02.012. Epub 2016 Feb 13.

18.

Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma.

Miller DM, Murray TG, Cicciarelli NL, Capo H, Markoe AM.

Ophthalmology. 2005 Sep;112(9):1620-4.

PMID:
16024083
20.

Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

Friedman DN, Sklar CA, Oeffinger KC, Kernan NA, Khakoo Y, Marr BP, Wolden SL, Abramson DH, Dunkel IJ.

Pediatr Blood Cancer. 2013 Apr;60(4):694-9. doi: 10.1002/pbc.24280. Epub 2012 Aug 21.

PMID:
22911631

Supplemental Content

Support Center